Advertisement
Screener

INTELLIA THERAPEUTICS, INC. (NTLA) EBITDA

Intellia Therapeutics, Inc. EBITDA

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of the cash a company's operations generate before accounting charges for wearing out its assets. Here it is operating income plus the filed depreciation and amortization, not a figure the company adjusted itself. Higher EBITDA means more operating profit before those charges. It is not an official accounting (GAAP) measure and does not subtract capital spending, interest or tax, so it does not show what those obligations cost.

  • Intellia Therapeutics, Inc. ebitda for the quarter ending 2026-06-30 was -$110.66M, a change of -$3.16M year-over-year.
  • Intellia Therapeutics, Inc. ebitda for the quarter ending 2026-03-31 was -$98.33M, a change of $19.98M year-over-year.
  • Intellia Therapeutics, Inc. ebitda for the quarter ending 2025-12-31 was -$96.33M, a change of $37.55M year-over-year.
  • Intellia Therapeutics, Inc. ebitda for the quarter ending 2025-09-30 was -$109.08M, a change of $33.09M year-over-year.
  • Intellia Therapeutics, Inc. ebitda for fiscal 2025 was -$431.22M, a change of $92.76M from fiscal 2024.
  • Intellia Therapeutics, Inc. ebitda for fiscal 2024 was -$523.98M, a change of -$17.66M from fiscal 2023.
  • Intellia Therapeutics, Inc. ebitda for fiscal 2023 was -$506.32M, a change of -$55.72M from fiscal 2022.
  • Intellia Therapeutics, Inc. ebitda for fiscal 2022 was -$450.59M, a change of -$189.63M from fiscal 2021.
Available history
2015-03-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$110.66M-$112.76M$2.1M(m)-1444.84%$1.81M*-$83.11M*(m)$82.59M(m)(m)
2026-03-31Reported-$98.33M-$100.53M$2.2M(m)-653.44%$79.00K-$117.35M(m)$80.74M(m)(m)
2025-12-31Reported-$96.33M-$98.71M$2.38M(m)-418.52%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$109.08M-$111.48M$2.4M(m)-791.45%$29.00K*-$76.90M*(m)$94.75M(m)(m)
2025-06-30Reported-$107.5M-$110M$2.5M(m)-754.62%$239.00K*-$99.62M*(m)$97.03M(m)(m)
2025-03-31Reported-$118.31M-$120.81M$2.5M(m)-711.55%$735.00K-$148.93M(m)$108.43M(m)(m)
2024-12-31Reported-$133.88M-$136.45M$2.57M(m)-1039.93%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$142.17M-$144.77M$2.6M(m)-1560.42%$1.28M*-$84.84M*(m)$123.38M(m)(m)
2024-06-30Reported-$136.44M-$139.04M$2.6M(m)-1961.23%$1.01M*-$58.19M*(m)$114.21M(m)(m)
2024-03-31Reported-$111.49M-$114M$2.51M(m)-385.32%$2.51M-$120.66M(m)$111.85M(m)(m)
2023-12-31Reported-$137.43M-$139.89M$2.47M(m)7168.81%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$128.82M-$131.11M$2.29M(m)(m)$4.33M*-$101.38M*(m)$113.70M(m)(m)
2023-06-30Reported-$130.16M-$132.33M$2.17M(m)(m)$4.30M*-$90.32M*(m)$115.28M(m)(m)
2023-03-31Reported-$109.91M-$111.96M$2.05M(m)-871.87%$3.83M-$109.33M(m)$97.12M(m)(m)
2022-12-31Reported-$108.06M-$110.09M$2.03M(m)-796.11%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$103.58M-$105.53M$1.95M(m)(m)$4.24M*-$78.53M*(m)$96.65M(m)(m)
2022-06-30Reported-$96.46M-$98.3M$1.84M(m)(m)$3.98M*-$85.09M*(m)$90.20M(m)(m)
2022-03-31Reported-$142.49M-$144.25M$1.75M(m)-1266.37%$1.43M-$79.80M(m)$133.09M(m)(m)
2021-12-31Reported-$78.54M-$80.42M$1.88M(m)-610.98%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$70.21M-$71.99M$1.79M(m)(m)$4.54M*-$65.02M*(m)$60.49M(m)(m)
2021-06-30Reported-$67.38M-$69.02M$1.63M(m)(m)$2.94M*-$52.98M*(m)$58.88M(m)(m)
2021-03-31Reported-$44.83M-$46.43M$1.59M(m)-695.64%$2.41M-$52.38M(m)$39.28M(m)(m)
2020-12-31Reported-$40.8M-$42.4M$1.6M(m)-618.61%(m)(m)(m)$38.23M(m)(m)
2020-09-30Reported-$26.5M-$28.1M$1.6M(m)(m)$698.00K*-$28.56M*(m)$39.76M(m)(m)
2020-06-30Reported-$31.47M-$33.03M$1.57M(m)(m)$1.04M*$57.42M*(m)$37.77M(m)(m)
2020-03-31Reported-$31.51M-$33.05M$1.54M(m)-243.94%$845.00K-$38.55M(m)$34.65M(m)(m)
2019-12-31Reported-$28.21M-$29.77M$1.57M(m)-257.91%(m)(m)(m)$31.73M(m)(m)
2019-09-30Reported-$23.95M-$25.33M$1.38M(m)(m)$1.75M*-$25.45M*$0.00*$27.51M(m)(m)
2019-06-30Reported-$26.12M-$27.46M$1.34M(m)(m)$941.00K*-$27.68M*$0.00*$25.46M(m)(m)
2019-03-31Reported-$22.51M-$23.81M$1.3M(m)-215.75%$1.53M-$21.45M$0.00$23.71M(m)(m)
2018-12-31Reported-$19.52M-$20.75M$1.23M(m)-247.70%(m)(m)(m)$19.92M(m)(m)
2018-09-30Reported-$22.95M-$24.1M$1.15M(m)(m)$2.02M*-$12.45M*$0.00*$23.24M(m)(m)
2018-06-30Reported-$22.52M-$23.6M$1.07M(m)(m)$900.00K*-$22.50M*(m)$23.47M(m)(m)
2018-03-31Reported-$21.42M-$22.43M$1.01M(m)-286.76%$1.85M-$17.77M(m)$22.49M(m)(m)
2017-12-31Reported-$23.88M-$24.72M$833,000.00(m)-358.16%(m)(m)(m)$21.17M(m)(m)
2017-09-30Reported-$15.09M-$15.88M$790,000.00(m)(m)$2.26M*-$16.89M*(m)$17.48M(m)(m)
2017-06-30Reported-$15.31M-$16.02M$711,000.00(m)(m)$1.27M*(m)(m)$15.56M(m)(m)
2017-03-31Reported-$12.29M-$12.95M$660,000.00(m)(m)$4.16M(m)(m)$13.43M(m)(m)
2016-12-31Reported-$10.42M-$10.82M$405,000.00(m)(m)(m)(m)(m)$11.33M(m)(m)
2016-09-30Reported-$7.43M-$7.7M$265,000.00(m)(m)$605.00K*(m)(m)$7.86M(m)$0.00
2016-06-30Reported-$6.7M-$6.95M$247,000.00(m)(m)$1.15M*(m)(m)$7.42M(m)$0.00
2016-03-31Reported-$6.51M-$6.69M$187,000.00(m)(m)$1.01M(m)(m)$5.22M(m)$0.00
2015-12-31Reported-$5.39M-$5.49M$104,000.00(m)(m)(m)(m)(m)$4.38M(m)-$246.00K
2015-09-30Reported-$3.21M-$3.3M$96,000.00(m)(m)$602.00K*(m)(m)$3.46M(m)-$282.00K
2015-06-30Reported-$3.36M-$3.42M$67,000.00(m)(m)$587.00K*(m)(m)$1.97M(m)-$382.00K
2015-03-31Reported-$1.16M-$1.2M$33,000.00(m)(m)$516.00K(m)(m)$1.37M(m)-$102.00K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$431.22M-$440.99M$9.77M(m)-637.23%$1.13M-$394.74M(m)$388.86M(m)$0.00
2024-12-31Reported-$523.98M-$534.26M$10.29M(m)-905.33%$5.78M-$348.88M(m)$466.31M(m)(m)
2023-12-31Reported-$506.32M-$515.29M$8.98M(m)-1395.77%$13.98M-$394.09M(m)$435.07M(m)(m)
2022-12-31Reported-$450.59M-$458.16M$7.57M(m)-864.51%$13.56M-$333.29M(m)$419.98M(m)(m)
2021-12-31Reported-$260.96M-$267.85M$6.89M(m)-789.52%$12.76M-$225.03M$0.00$229.81M(m)(m)
2021-09-30Rolling(m)-$229.83M*(m)$26.79M*(m)(m)(m)(m)$196.88M*(m)(m)
2021-06-30Rolling(m)-$185.94M*(m)$41.81M*(m)(m)(m)(m)$176.15M*(m)(m)
2021-03-31Rolling(m)-$149.96M*(m)$51.52M*(m)(m)(m)(m)$155.03M*(m)(m)
2020-12-31Reported-$130.27M-$136.58M$6.31M(m)-224.63%$3.58M-$49.91M$0.00$150.41M(m)(m)
2020-12-31Rolling(m)-$136.58M*(m)$57.99M*(m)(m)(m)(m)$150.41M*(m)(m)
2020-09-30Rolling(m)-$123.95M*(m)$62.34M*(m)(m)(m)(m)$143.91M*(m)(m)
2020-06-30Rolling(m)-$121.18M*(m)$50.73M*(m)(m)(m)(m)$131.66M*(m)(m)
2020-03-31Rolling(m)-$115.61M*(m)$45.59M*(m)(m)(m)(m)$119.35M*(m)(m)
2019-12-31Reported-$100.78M-$106.37M$5.59M(m)-233.81%$6.79M-$103.24M$0.00$108.41M(m)(m)
2019-12-31Rolling(m)-$106.37M*(m)$43.10M*(m)(m)(m)(m)$108.41M*(m)(m)
2019-09-30Rolling(m)-$97.34M*(m)$40.05M*(m)(m)(m)(m)$96.60M*(m)(m)
2019-06-30Rolling(m)-$96.11M*(m)$36.84M*(m)(m)(m)(m)$92.32M*(m)(m)
2019-03-31Rolling(m)-$92.25M*(m)$33.40M*(m)(m)(m)(m)$90.33M*(m)(m)
2018-12-31Reported-$86.41M-$90.87M$4.46M(m)-283.91%$6.36M-$61.26M$0.00$89.11M(m)(m)
2018-12-31Rolling(m)-$90.87M*(m)$30.43M*(m)(m)(m)(m)$89.11M*(m)(m)
2018-09-30Rolling(m)-$94.84M*(m)$29.22M*(m)(m)(m)(m)$90.37M*(m)(m)
2018-06-30Rolling(m)-$86.61M*(m)$29.13M*(m)(m)(m)(m)$84.61M*(m)(m)
2018-03-31Rolling(m)-$79.04M*(m)$27.37M*(m)(m)(m)(m)$76.71M*(m)(m)
2017-12-31Reported-$66.56M-$69.56M$2.99M(m)-254.86%$10.09M-$65.28M(m)$67.65M(m)(m)
2017-12-31Rolling(m)-$69.56M*(m)$26.12M*(m)(m)(m)(m)$67.65M*(m)(m)
2017-09-30Rolling(m)-$55.66M*(m)(m)(m)(m)(m)(m)$57.81M*(m)(m)
2017-06-30Rolling(m)-$47.48M*(m)(m)(m)(m)(m)(m)$48.19M*(m)(m)
2017-03-31Rolling(m)-$38.41M*(m)(m)(m)(m)(m)(m)$40.05M*(m)(m)
2016-12-31Reported-$31.06M-$32.16M$1.1M(m)-188.45%$6.17M$36.11M(m)$31.84M(m)$0.00
2016-12-31Rolling(m)-$32.16M*(m)(m)(m)(m)(m)(m)$31.84M*(m)(m)
2016-09-30Rolling(m)-$26.83M*(m)(m)(m)(m)(m)(m)$24.88M*(m)-$246.00K*
2016-06-30Rolling(m)-$22.43M*(m)(m)(m)(m)(m)(m)$20.48M*(m)-$528.00K*
2016-03-31Rolling(m)-$18.91M*(m)(m)(m)(m)(m)(m)$15.02M*(m)-$910.00K*
2015-12-31Reported-$13.08M-$13.41M$328,000.00(m)(m)$2.55M(m)(m)$11.17M(m)-$1.01M
2015-12-31Rolling(m)-$13.41M*(m)(m)(m)(m)(m)(m)$11.17M*(m)-$1.01M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
NEOGEN CORP (NEOG)United States$2.979B-247.49
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93